About Andrew Holman, M.D.
Andrew Holman, M.D., is chief executive officer of Inmedix, Inc., and a director. Inmedix makes CloudHRV, a heart rate variability diagnostic that received FDA clearance in January 2025. CloudHRV reports heart rate variability from a five-minute resting ECG taken in the clinic.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Holman, M.D. in the role, so the role may have started earlier or lasted longer.
Inmedix, Inc. Current
Co-Founder, President & Chief Executive Officer, director
CEO & Director
2023 – Present · Normandy Park, WA
CloudHRV is a five-minute ECG-based diagnostic that gives clinicians a report on autonomic nervous system activity.
Key Colleagues at Startups
The people Andrew Holman, M.D. works with at each company, as listed on that company's latest Form D.
Inmedix, Inc. · Form D/A, Oct 22, 2026
SA
Steven Daly, M.S., M.B.A.
Chief Operating Officer and director
Bernie Tobin
Independent Member of the Board of Directors
LD
Leroy Hood, M.D., Ph.D.
Director
KD
Kevin Tracey, M.D.
Director
RD
Ryan Sullivan, Ph.D.
Director